NumanHealth1 / 11Read in the appPitch deck
The deck, and the 4 rounds we watched Numan raise afterwards, with the investors each report named.
Numan is a UK-based digital healthcare provider founded in 2018 and headquartered in London. The company specializes in personalized, technology-driven treatments for men's health conditions, including erectile dysfunction, hair loss, weight management, and hormonal balance. Numan is regulated by the Care Quality Commission (CQC) and employs GMC-registered doctors and GPhC-registered pharmacists to ensure high-quality care. The company offers an integrated digital platform that provides a range of services, including one-on-one consultations, blood tests, direct-to-consumer medications, personalized supplement plans, and behavioral health coaching. Numan emphasizes accessibility, allowing users to access services from anywhere in the UK, with a focus on privacy and discretion. With over 500,000 members and significant growth, Numan continues to expand its offerings and enhance its platform to meet the needs of men seeking convenient healthcare solutions.
Read the deckFree account. The deck belongs to Numan, so reading it needs one; everything on this page is public.
What is in it
Each slide by what it argues. 11 slides against a median of 13 across the 1,712 decks we hold.
CoverMarketGo to marketProduct
What happened next
1 / 11The deck itself
All 11 slides, each read for what it argues and set against the decks that raised at the same stage. The cover is shown here; the rest is read in the app.
Read the deck →Free account. The deck belongs to Numan.
Firms listing Numan on their own portfolio page: the firm's own account rather than a round we watched. Weaker than an announcement, much stronger than a list somebody sold us.
Browse all 1,712 decks. We hold no record of where this file came from or on what terms. If it is yours and you would rather it were not here, tell us and it goes.